LANSOPRAZOLE and DYSPNOEA

Overview

DYSPNOEA is the #8 most commonly reported adverse reaction for LANSOPRAZOLE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 7,948 FDA adverse event reports linking LANSOPRAZOLE to DYSPNOEA. This represents approximately 2.0% of all 389,756 adverse event reports for this drug.

Patients taking LANSOPRAZOLE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for LANSOPRAZOLE, but still significant enough to appear in the safety profile.

Other Side Effects of LANSOPRAZOLE

In addition to dyspnoea, the following adverse reactions have been reported for LANSOPRAZOLE:

• CHRONIC KIDNEY DISEASE — 32,775 reports
• ACUTE KIDNEY INJURY — 18,670 reports
• RENAL FAILURE — 13,812 reports
• END STAGE RENAL DISEASE — 9,782 reports
• RENAL INJURY — 9,519 reports
• NAUSEA — 8,961 reports
• DIARRHOEA — 8,752 reports
• FATIGUE — 7,636 reports
• VOMITING — 7,061 reports
• OFF LABEL USE — 6,871 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does LANSOPRAZOLE cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 7,948 FDA reports for LANSOPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with LANSOPRAZOLE?

DYSPNOEA accounts for approximately 2.0% of all adverse event reports for LANSOPRAZOLE, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking LANSOPRAZOLE?

If you experience dyspnoea while taking LANSOPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages